跳至主要内容
临床试验/CTRI/2019/11/021869
CTRI/2019/11/021869已完成3 期

Efficacy and safety of exercise in mild to moderate myasthenia gravis: an openlabeled controlled trial.

Prinicipal Investigator1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月27日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
MGQOL-15 score

研究概览

简要总结

Myasthenia gravis (MG) is a rare autoimmune disease of neuromuscular junction. MG manifests with fatigability and fluctuating weakness of ocular, facial bulbar respiratory, axial and limb muscles.Exercise training is safe nonpharmacological intervention and may have physical and psychological advantages in MG.  There is no randomised controlled trial on the efficacy and safety of exercise in MG .The present study is aimed at evaluating the efficacy and safety of exercise or rest in mild to moderate MG.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
15.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • MG patients attending the neurology Outdoor or indoor services of SGPGIMS.
  • MGFA score of stage II to III.
  • Able to undergo 6minute walk test.

排除标准

  • Enrolled in another trial.
  • Contraindications to exercise like coronary artery disease and stroke and pulmonary disease, osteoarthritis, pregnancy or medical condition reducing survival to less than 2 years.
  • Hospitalization in past 8 weeks.
  • MGFA score of stage I, IV or V.
  • MGQOL score > 45.

结局指标

主要结局

MGQOL-15 score

时间窗: 1,2 and 3 months

次要结局

  • 1. Increase in the dose of AchEIs drugs or additional immunosuppression or use of PE,IVIG.(2. Myasthenic muscle score: at 1,2 and 3 month.)

研究者

发起方
Prinicipal Investigator
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验